Laboratory Testing for Central Hypothyroidism
Measure serum free T4 (fT4) and TSH together to evaluate central hypothyroidism 1. This two-test combination is the recommended first-line approach, as TSH alone cannot diagnose central hypothyroidism and may be low, normal, or even mildly elevated despite true hypothyroidism.
Diagnostic Laboratory Algorithm
Initial Testing
- Free T4 (fT4): The critical test for diagnosis
- TSH: Measured simultaneously but interpreted differently than in primary hypothyroidism
Diagnostic Interpretation
The diagnosis is confirmed when fT4 falls below the laboratory reference range in conjunction with a low, normal, or mildly elevated TSH in patients with known or suspected pituitary disease 1.
Key diagnostic pitfall: Unlike primary hypothyroidism where TSH is markedly elevated, central hypothyroidism presents with an inappropriately normal or low TSH relative to the low thyroid hormone levels. The TSH fails to rise appropriately because the problem originates in the pituitary or hypothalamus, not the thyroid gland itself.
Additional Considerations for Borderline Cases
Low-Normal Free T4 Scenarios
When fT4 levels are in the low-normal range (lowest third of normal) but still technically within reference range, and central hypothyroidism is suspected based on pituitary disease:
- Consider treatment initiation if suggestive symptoms are present 1
- Alternative approach: Monitor fT4 levels over time and start treatment if fT4 decreases by ≥20% 1
- Free T4 index (FTI) may provide additional diagnostic value in these borderline cases, as some patients with normal fT4 by direct immunoassay show low FTI 2
Dynamic Testing: Generally Not Recommended
Do not use TRH stimulation testing for routine diagnosis of central hypothyroidism 1. The Endocrine Society guidelines explicitly recommend against dynamic TSH-secretion testing, as static measurements of fT4 and TSH are sufficient for diagnosis in most cases.
Exception: Recent research suggests TRH testing may identify hidden cases in patients with pituitary tumors and normal fT4 levels 3, 4, but this remains outside standard guideline recommendations and should be reserved for specialized centers evaluating complex cases.
Critical Pre-Testing Consideration
Rule out adrenal insufficiency first 5. If adrenal insufficiency is present or suspected, initiate glucocorticoid therapy before diagnosing or treating central hypothyroidism, as:
- TSH levels may be falsely elevated with untreated adrenal insufficiency
- TSH may normalize with glucocorticoid therapy alone
- Starting thyroid hormone replacement before addressing adrenal insufficiency can precipitate adrenal crisis
Monitoring During Treatment
Use free T4, NOT TSH, to guide therapy and monitor treatment adequacy 5, 6. The goal is to achieve fT4 levels above the mean for the assay being used, as treated patients typically require higher fT4 levels than untreated controls to achieve clinical euthyroidism 5.
Measure fT4 levels:
- Before taking the daily levothyroxine dose
- 4-8 weeks after initiating therapy or dose adjustments
- TSH remains unreliable for monitoring because the underlying pituitary dysfunction persists
Summary of Essential Labs
Required for diagnosis:
- Serum free T4
- Serum TSH
Optional/situational:
- Free T4 index (when fT4 is low-normal and diagnosis uncertain)
- Cortisol assessment (to exclude adrenal insufficiency before treatment)
- TRH stimulation test (not routinely recommended per guidelines, though may have utility in specialized scenarios)